India-US trade deal: Commerce Ministry shares update on Piyush Goyal’s visit; says aim to ‘achieve early conclusion’

A delegation headed by Piyush Goyal conducted an official visit to the US from September 22-24, 2025. (AI image) India-US trade deal talks: India and the US have decided to continue working towards an early conclusion to the trade agreement, according to a statement by the Ministry of Commerce & Industry.Sharing an update on Commerce…

Read More

Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in

For Indian pharmaceutical exports, the US represents the primary market, comprising about 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…

Read More

Gold price prediction: What’s the outlook for September 26, 2025? Why a ‘sell on rise’ strategy makes sense

Gold’s intraday structure favors a sell-on-rise strategy as the EMA crossover, MACD positioning, and Bollinger resistance suggest limited upside. (AI image) Gold price prediction today: In today’s technical set-up gold prices signal a sell on rise strategy, says Jateen Trivedi, VP Research Analyst – Commodity and Currency, LKP Securities. Here is his strategy for gold…

Read More

Trump’s 100% tariffs on pharma: Sun Pharma, Biocon, Cipla & other pharmaceutical stocks tank; jitters on D-Street

Several prominent Indian pharmaceutical firms, including Sun Pharma, Dr. Reddy’s Laboratories, Cipla, Lupin, Aurobindo Pharma, and Zydus Lifesciences, maintain substantial export operations to the USA. (AI image) Pharma stocks hit by Trump’s tariffs: Pharmaceutical stocks declined sharply by up to 5% on Friday, September 26, following US President Donald Trump’s declaration of imposing 100% tariffs…

Read More